Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Intention-to-treat Effect of Bridging Therapies in the Setting of Milan-in Patients Waiting for Liver Transplantation

NCT03723304 is registered in ClinicalTrials.gov with European Hepatocellular Cancer Liver Transplant Group as lead sponsor.

NCT NCT03723304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03723304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Intention-to-treat Effect of Bridging Therapies in the Setting of Milan-in Patients Waiting for Liver Transplantation
Lead sponsor
European Hepatocellular Cancer Liver Transplant Group
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
October 15, 2018
Enrollment
1,083 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, transplant; failure, liver